Robynn Sturm, Advisor for Open Innovation to the Deputy Director of OSTP, witnessed a striking role-reversal in the field of biomedical research. The Dean of Harvard Medical School, Jeffrey S. Flier, a prominent diabetes researcher in his own right, listened intently as undergraduate Megan Blewett presented her pioneering proposal to advance Type One Diabetes research in promising new directions.